Delivery Order SPE2DR25D3109-SPE2DR26FT2KL
Award Date 12/18/25
Potential Completion Date 12/19/25
Potential Value $5.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,074.77 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units). This non-competitive delivery order, issued on April 22, 2025, with completion by April 23, 2025, represents a firm fixed-price transaction under DLA's pharmaceutical procurement framework. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,089.34 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) on December 2, 2025, with completion scheduled for December 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,898.67 to AmerisourceBergen Drug Corp for 30-count bottles of Xeljanz XR 11 mg tablets, with an ultimate completion date of December 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award represents a pharmaceutical supply delivery under DLA's medical procurement operations, supporting federal healthcare needs for military and veteran populations. AmerisourceBergen,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,738.95 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets in a quantity of 60 units. This firm fixed-price, non-set-aside delivery order was awarded on December 4, 2025, with an ultimate completion date of December 5, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,956.58 to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This non-set-aside, firm fixed price delivery order was competitively awarded on August 8, 2025, with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,785.42 to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets (30-count units) on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The product will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets (30-count units) valued at $8,107.66 under a firm fixed-price contract type. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supplies to federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,169.80 to supply Xeljanz XR 11 mg tablets (30-count units) under a firm fixed-price contract. The award, made on November 24, 2025, with an ultimate completion date of November 25, 2025, is a non-set-aside competitively awarded delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,940.08 to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets (30-count units) with completion targeted for October 20, 2025. This firm fixed-price, competitively awarded contract contains no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a specific pharmaceutical product delivery under AmerisourceBergen's existing contract vehicle with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,533.49 to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets (30-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price delivery order was competitively awarded without any set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction within DLA's...